Tetraspanins - gateways for infection

Infectious Disorders - Drug Targets

Volumn 12, Issue 1, 2012, Pages 4-17

  Monk, Peter N ^a   Partridge, Lynda J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Adhesion; Infectious disease; Membrane proteins; Tetraspanins

Indexed keywords

CELL MEMBRANE PROTEIN; MEMBRANE PROTEIN; SMALL INTERFERING RNA; TETRASPANIN;

ANTIBODY SPECIFICITY; CELL MIGRATION; HUMAN; IMMUNE RESPONSE; INFECTION; INTRACELLULAR BACTERIUM; MYCOSIS; NONHUMAN; PARASITOSIS; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SYNAPSE; VIRUS ENTRY; VIRUS INFECTION;

EID: 84855862367     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152612798994957     Document Type: Review

References (217)

1. Huang, S.; Tian, H.; Chen, Z.; Yu, T.; Xu, A. The evolution of vertebrate tetraspanins: gene loss, retention, and massive positive selection after whole genome duplications. BMC Evol. Biol., 2010, 10, 306.
2. Boucheix, C.; Rubinstein, E., Tetraspanins. Cell Mol. Life Sci., 2001, 58, (9), 1189-1205.
3. Miyado, K.; Yamada, G.; Yamada, S.; Hasuwa, H.; Nakamura, Y.; Ryu, F.; Suzuki, K.; Kosai, K.; Inoue, K.; Ogura, A.; Okabe, M.; Mekada, E. Requirement of CD9 on the egg plasma membrane for fertilization. Science, 2000, 287, (5451), 321-324.
4. Le Naour, F.; Rubinstein, E.; Jasmin, C.; Prenant, M.; Boucheix, C. Severely reduced female fertility in CD9-deficient mice. Science, 2000, 287, (5451), 319-321.
5. Yang, X.; Claas, C.; Kraeft, S. K.; Chen, L. B.; Wang, Z.; Kreidberg, J. A.; Hemler, M. E. Palmitoylation of Tetraspanin Proteins: Modulation of CD151 Lateral Interactions, Subcellular Distribution, and Integrin-dependent Cell Morphology. Mol. Biol. Cell, 2002, 13(3), 767-781.
6. Kitadokoro, K.; Bordo, D.; Galli, G.; Petracca, R.; Falugi, F.; Abrignani, S.; Grandi, G.; Bolognesi, M. CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. Embo J., 2001, 20, (1-2), 12-18.
7. Yanez-Mo, M.; Barreiro, O.; Gordon-Alonso, M.; Sala-Valdes, M.; Sanchez-Madrid, F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol., 2009, 19(9), 434-446.
8. Guess, C. M.; Quaranta, V. Defining the role of laminin-332 in carcinoma. Matrix Biol., 2009, 28, (8), 445-455.
9. Stipp, C. S. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev. Mol. Med., 2010, 12, e3.
10. Charrin, S.; le Naour, F.; Silvie, O.; Milhiet, P. E.; Boucheix, C.; Rubinstein, E. Lateral organization of membrane proteins: tetraspanins spin their web. Biochem. J., 2009, 420, (2), 133-154.
11. Boon, C. J.; den Hollander, A. I.; Hoyng, C. B.; Cremers, F. P.; Klevering, B. J.; Keunen, J. E. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog. Retin Eye Res., 2008, 27(2), 213-235.
12. Dryja, T. P.; Hahn, L. B.; Kajiwara, K.; Berson, E. L. Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci., 1997, 38, (10), 1972-1982.
13. Zemni, R.; Bienvenu, T.; Vinet, M. C.; Sefiani, A.; Carrie, A.; Billuart, P.; McDonell, N.; Couvert, P.; Francis, F.; Chafey, P.; Fauchereau, F.; Friocourt, G.; des Portes, V.; Cardona, A.; Frints, S.; Meindl, A.; Brandau, O.; Ronce, N.; Moraine, C.; van Bokhoven, H.; Ropers, H. H.; Sudbrak, R.; Kahn, A.; Fryns, J. P.; Beldjord, C.; Chelly, J. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet., 2000, 24, (2), 167-170.
14. Karamatic Crew, V.; Burton, N.; Kagan, A.; Green, C. A.; Levene, C.; Flinter, F.; Brady, R. L.; Daniels, G.; Anstee, D. J. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood, 2004, 104(8), 2217-2223
15. Karamatic Crew, V.; Poole, J.; Long, S.; Warke, N.; Colavecchia, C.; Burton, N.; Moulds, M.; Schlanser, G.; Wilson, L.; Noumsi, G.; Moulds, J. M.; Moulds, J. J.; Daniels, G. Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2. Transfusion, 2008, 48(9),1912-1916.
16. Yang, H.; Xiao, X.; Li, S.; Mai, G.; Zhang, Q. Novel TSPAN12 mutations in patients with familial exudative vitreoretinopathy and their associated phenotypes. Mol. Vis., 2011, 17, 1128-1135.
17. Junge, H. J.; Yang, S.; Burton, J. B.; Paes, K.; Shu, X.; French, D. M.; Costa, M.; Rice, D. S.; Ye, W., TSPAN12 regulates retinal vascular development by promoting Norrin-but not Wnt-induced FZD4/beta-catenin signaling. Cell, 2009, 139, (2), 299-311.
18. Nikopoulos, K.; Gilissen, C.; Hoischen, A.; van Nouhuys, C. E.; Boonstra, F. N.; Blokland, E. A.; Arts, P.; Wieskamp, N.; Strom, T. M.; Ayuso, C.; Tilanus, M. A.; Bouwhuis, S.; Mukhopadhyay, A.; Scheffer, H.; Hoefsloot, L. H.; Veltman, J. A.; Cremers, F. P.; Collin, R. W. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am. J. Hum. Genet., 2010, 86, (2), 240-247.
19. Pan, Y.; Geisert, D. F.; Orr, W. E.; Geisert, E. E. The effects of a CD81 null mutation on retinal pigment epithelium in mice. Neurochem. Res., 2011, 36, (4), 569-573.
20. Pols, M. S.; Klumperman, J. Trafficking and function of the tetraspanin CD63. Exp. Cell Res., 2009, 315, (9), 1584-1592.
21. Yoshida, T.; Ebina, H.; Koyanagi, Y. N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol. Immunol., 2009, 53(11), 629-635.
22. Kallquist, L.; Hansson, M.; Persson, A. M.; Janssen, H.; Calafat, J.; Tapper, H.; Olsson, I. The tetraspanin CD63 is involved in granule targeting of neutrophil elastase. Blood, 2008, 112(8), 3444-3454.
23. Flannery, A. R.; Czibener, C.; Andrews, N. W. Palmitoylationdependent association with CD63 targets the Ca2+ sensor synaptotagmin VII to lysosomes. J. Cell Biol., 2010, 191(3), 599-613.
24. Simons, M.; Raposo, G. Exosomes--vesicular carriers for intercellular communication. Curr. Opin. Cell Biol., 2009, 21, (4), 575-581.
25. Blanc, L.; De Gassart, A.; Geminard, C.; Bette-Bobillo, P.; Vidal, M. Exosome release by reticulocytes--an integral part of the red blood cell differentiation system. Blood Cells Mol. Dis., 2005, 35, (1), 21-26.
26. Thery, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol., 2009, 9(8), 581-593.
27. Liegeois, S.; Benedetto, A.; Garnier, J. M.; Schwab, Y.; Labouesse, M. The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans. J. Cell Biol., 2006, 173(6), 949-961.
28. Kolotuev, I.; Apaydin, A.; Labouesse, M. Secretion of Hedgehogrelated peptides and WNT during Caenorhabditis elegans development. Traffic, 2009, 10(7), 803-810.
29. Yu, X.; Harris, S. L.; Levine, A. J. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res., 2006, 66(9), 4795-4801.
30. Keller, S.; Sanderson, M. P.; Stoeck, A.; Altevogt, P. Exosomes: from biogenesis and secretion to biological function. Immunol. Lett., 2006, 107(2), 102-108.
31. Gould, S. J.; Booth, A. M.; Hildreth, J. E. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA, 2003, 100(19), 10592-10597.
32. Fang, Y.; Wu, N.; Gan, X.; Yan, W.; Morrell, J. C.; Gould, S. J. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol., 2007, 5(6), e158.
33. Logozzi, M.; De Milito, A.; Lugini, L.; Borghi, M.; Calabro, L.; Spada, M.; Perdicchio, M.; Marino, M. L.; Federici, C.; Iessi, E.; Brambilla, D.; Venturi, G.; Lozupone, F.; Santinami, M.; Huber, V.; Maio, M.; Rivoltini, L.; Fais, S. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE, 2009, 4(4), e5219.
34. Nazarenko, I.; Rana, S.; Baumann, A.; McAlear, J.; Hellwig, A.; Trendelenburg, M.; Lochnit, G.; Preissner, K. T.; Zoller, M. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res., 2010, 70(4), 1668-1678.
35. Subra, C.; Laulagnier, K.; Perret, B.; Record, M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie, 2007, 89(2), 205-512.
36. Rana, S.; Zoller, M. Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem. Soc. Trans., 2011, 39(2), 559-562.
37. Pols, M. S.; Klumperman, J. Trafficking and function of the tetraspanin CD63. Exp. Cell Res., 2009, 315(9),1584-1592
38. Danglot, L.; Chaineau, M.; Dahan, M.; Gendron, M. C.; Boggetto, N.; Perez, F.; Galli, T. Role of TI-VAMP and CD82 in EGFR cellsurface dynamics and signaling. J. Cell Sci., 2010, 123, (Pt 5), 723-735.
39. Moseley, G. W. Tetraspanin-Fc receptor interactions. Platelets, 2005, 16(1), 3-12.
40. Skubitz, K. M.; Campbell, K. D.; Iida, J.; Skubitz, A. P. CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils. J. Immunol., 1996, 157(8), 3617-3626.
41. Dijkstra, S.; Geisert, E. E. Jr.; Dijkstra, C. D.; Bar, P. R.; Joosten, E. A. CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production. J. Neuroimmunol., 2001, 114(1-2), 151-159.
42. Chang, Y.; Finnemann, S. C. Tetraspanin CD81 is required for the alpha v beta5-integrin-dependent particle-binding step of RPE phagocytosis. J. Cell Sci., 2007, 120(Pt 17), 3053-3063.
43. Cantin, R.; Methot, S.; Tremblay, M. J. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J. Virol., 2005, 79(11), 6577-6587.
44. Lindenbach, B. D.; Thiel, H. J.; Rice, C. M. Flaviviridae: The Viruses and their Replication. In Fields Virology, Knipe, D. M.; Howley, P. M. Eds. Lippincott Williams & Wilkins: Philadelphia, 2007; pp 1101-1152.
45. Lemon, S. M.; Walker, C.; Alter, M. J.; Yi, M. Hepatitis C Virus. In Fields Virology, Knipe, D. M.; Howley, P. M., Eds. Lippincott Williams & Wilkins: Philadelphia, 2007; pp 1253-1304.
46. Manns, M. P.; Wedemeyer, H.; Cornberg, M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut, 2006, 55, (9), 1350-1359.
47. Op De Beeck, A.; Cocquerel, L.; Dubuisson, J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol., 2001, 82, (Pt 11), 2589-2595.
48. Pileri, P.; Uematsu, Y.; Campagnoli, S.; Galli, G.; Falugi, F.; Petracca, R.; Weiner, A. J.; Houghton, M.; Rosa, D.; Grandi, G.; Abrignani, S. Binding of hepatitis C virus to CD81. Science, 1998, 282, (5390), 938-941.
49. Flint, M.; Maidens, C.; Loomis-Price, L. D.; Shotton, C.; Dubuisson, J.; Monk, P.; Higginbottom, A.; Levy, S.; McKeating, J. A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor. CD81. J. Virol., 1999, 73(8), 6235-6244.
50. Higginbottom, A.; Quinn, E. R.; Kuo, C. C.; Flint, M.; Wilson, L. H.; Bianchi, E.; Nicosia, A.; Monk, P. N.; McKeating, J. A.; Levy, S. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J. Virol., 2000, 74(8), 3642-3649.
51. Petracca, R.; Falugi, F.; Galli, G.; Norais, N.; Rosa, D.; Campagnoli, S.; Burgio, V.; Di Stasio, E.; Giardina, B.; Houghton, M.; Abrignani, S.; Grandi, G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol., 2000, 74(10), 4824-4830.
52. Lambotin, M.; Baumert, T. F.; Barth, H. Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells. J. Virol., 2010, 84(17), 8964-8969.
53. Scarselli, E.; Ansuini, H.; Cerino, R.; Roccasecca, R. M.; Acali, S.; Filocamo, G.; Traboni, C.; Nicosia, A.; Cortese, R.; Vitelli, A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo J., 2002, 21(19), 5017-5025.
54. Eyre, N. S.; Drummer, H. E.; Beard, M. R. The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog., 2010, 6, (10), e1001130
55. Ploss, A.; Evans, M. J.; Gaysinskaya, V. A.; Panis, M.; You, H.; de Jong, Y. P.; Rice, C. M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature, 2009, 457, (7231), 882-886.
56. Evans, M. J.; von Hahn, T.; Tscherne, D. M.; Syder, A. J.; Panis, M.; Wolk, B.; Hatziioannou, T.; McKeating, J. A.; Bieniasz, P. D.; Rice, C. M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, 2007, 446, (7137), 801-805.
57. Zheng, C. F.; Ma, L. L.; Jones, G. J.; Gill, M. J.; Krensky, A. M.; Kubes, P.; Mody, C. H. Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. Blood, 2007, 109, (5), 2049-2057.
58. Meertens, L.; Bertaux, C.; Cukierman, L.; Cormier, E.; Lavillette, D.; Cosset, F. L.; Dragic, T., The tight junction proteins claudin-1,-6, and-9 are entry cofactors for hepatitis C virus. J. Virol., 2008, 82(7), 3555-3560.
59. Perrault, M.; Pecheur, E. I. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership. Biochem. J., 2009, 423(3), 303-314.
60. Mee, C. J.; Grove, J.; Harris, H. J.; Hu, K.; Balfe, P.; McKeating, J. A. Effect of cell polarization on hepatitis C virus entry. J. Virol., 2008, 82(1), 461-470.
61. Mee, C. J.; Harris, H. J.; Farquhar, M. J.; Wilson, G.; Reynolds, G.; Davis, C.; van, I. S. C.; Balfe, P.; McKeating, J. A. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J. Virol., 2009, 83(12), 6211-6221.
62. Montpellier, C.; Tews, B. A.; Poitrimole, J.; Rocha-Perugini, V.; D'Arienzo, V.; Potel, J.; Zhang, X. A.; Rubinstein, E.; Dubuisson, J.; Cocquerel, L. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint and their effect on Hepatitis C Virus infection. J. Biol. Chem., 2011, 286(16),13954-13965
63. Rocha-Perugini, V.; Montpellier, C.; Delgrange, D.; Wychowski, C.; Helle, F.; Pillez, A.; Drobecq, H.; Le Naour, F.; Charrin, S.; Levy, S.; Rubinstein, E.; Dubuisson, J.; Cocquerel, L. The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS ONE, 2008, 3(4), e1866
64. Schuster, C.; Baumert, T. F. EWI-2wint--a host cell factor inhibiting hepatitis C virus entry. J. Hepatol., 2009, 50(1), 222-224.
65. Rocha-Perugini, V.; Lavie, M.; Delgrange, D.; Canton, J.; Pillez, A.; Potel, J.; Lecoeur, C.; Rubinstein, E.; Dubuisson, J.; Wychowski, C.; Cocquerel, L. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C Virus entry. BMC Microbiol., 2009, 9(1), 111.
66. Roccasecca, R.; Ansuini, H.; Vitelli, A.; Meola, A.; Scarselli, E.; Acali, S.; Pezzanera, M.; Ercole, B. B.; McKeating, J.; Yagnik, A.; Lahm, A.; Tramontano, A.; Cortese, R.; Nicosia, A. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J. Virol., 2003, 77, (3), 1856-1867.
67. Bitzegeio, J.; Bankwitz, D.; Hueging, K.; Haid, S.; Brohm, C.; Zeisel, M. B.; Herrmann, E.; Iken, M.; Ott, M.; Baumert, T. F.; Pietschmann, T. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog., 2010, 6, e1000978.
68. Coller, K. E.; Berger, K. L.; Heaton, N. S.; Cooper, J. D.; Yoon, R.; Randall, G. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog., 2009, 5(12), e1000702.
69. Bartosch, B.; Vitelli, A.; Granier, C.; Goujon, C.; Dubuisson, J.; Pascale, S.; Scarselli, E.; Cortese, R.; Nicosia, A.; Cosset, F. L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem., 2003, 278(43), 41624-41630.
70. Zhang, Y. Y.; Zhang, B. H.; Ishii, K.; Liang, T. J. Novel function of CD81 in controlling hepatitis C virus replication. J. Virol., 2010, 84(7), 3396-3407.
71. Masciopinto, F.; Giovani, C.; Campagnoli, S.; Galli-Stampino, L.; Colombatto, P.; Brunetto, M.; Yen, T. S.; Houghton, M.; Pileri, P.; Abrignani, S. Association of hepatitis C virus envelope proteins with exosomes. Eur. J. Immunol., 2004, 34, (10), 2834-2842.
72. Gartner, S.; Markovits, P.; Markovitz, D. M.; Kaplan, M. H.; Gallo, R. C.; Popovic, M. The role of mononuclear phagocytes in HTLVIII/ LAV infection. Science, 1986, 233(4760), 215-219.
73. von Lindern, J. J.; Rojo, D.; Grovit-Ferbas, K.; Yeramian, C.; Deng, C.; Herbein, G.; Ferguson, M. R.; Pappas, T. C.; Decker, J. M.; Singh, A.; Collman, R. G.; O'Brien, W. A. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol., 2003, 77(6), 3624-3633.
74. Ho, S. H.; Martin, F.; Higginbottom, A.; Partridge, L. J.; Parthasarathy, V.; Moseley, G. W.; Lopez, P.; Cheng-Mayer, C.; Monk, P. N. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J. Virol., 2006, 80(13), 6487-6496.
75. Chen, H.; Dziuba, N.; Friedrich, B.; von Lindern, J.; Murray, J. L.; Rojo, D. R.; Hodge, T. W.; O'Brien, W. A.; Ferguson, M. R. A critical role for CD63 in HIV replication and infection of macrophages and cell lines. Virology, 2008, 379(2), 191-196.
76. Li, G.; Dziuba, N.; Friedrich, B.; Murray, J. L.; Ferguson, M. R. A post-entry role for CD63 in early HIV-1 replication. Virology, 2011, 412(2),315-324.
77. Zaitseva, M.; Romantseva, T.; Manischewitz, J.; Wang, J.; Goucher, D.; Golding, H. Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association. J. Leukoc. Biol., 2005, 78(6), 1306-1317.
78. Yoshida, T.; Kawano, Y.; Sato, K.; Ando, Y.; Aoki, J.; Miura, Y.; Komano, J.; Tanaka, Y.; Koyanagi, Y. A CD63 mutant inhibits Tcell tropic human immunodeficiency virus type 1 entry by disrupting CXCR4 trafficking to the plasma membrane. Traffic, 2008, 9(4), 540-558.
79. Fournier, M.; Peyrou, M.; Bourgoin, L.; Maeder, C.; Tchou, I.; Foti, M. CD4 dimerization requires two cysteines in the cytoplasmic domain of the molecule and occurs in microdomains distinct from lipid rafts. Mol. Immunol., 2010, 47(16), 2594-2603.
80. Bourgeois, R.; Mercier, J.; Paquette-Brooks, I.; Cohen, E. A. Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry. Retrovirology, 2006, 3, 31.
81. Vidricaire, G.; Imbeault, M.; Tremblay, M. J. Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J. Virol., 2004, 78(21), 11904-11915.
82. Vidricaire, G.; Tremblay, M. J. A clathrin, caveolae, and dynaminindependent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J. Mol. Biol., 2007, 368(5), 1267-1283.
83. Zheng, J.; Xie, Y.; Campbell, R.; Song, J.; Massachi, S.; Razi, M.; Chiu, R.; Berenson, J.; Yang, O. O.; Chen, I. S.; Pang, S. Involvement of claudin-7 in HIV infection of CD4(-) cells. Retrovirology, 2005, 2, 79.
84. Meerloo, T.; Parmentier, H. K.; Osterhaus, A. D.; Goudsmit, J.; Schuurman, H. J. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. Aids, 1992, 6(10), 1105-1116.
85. Meerloo, T.; Sheikh, M. A.; Bloem, A. C.; de Ronde, A.; Schutten, M.; van Els, C. A.; Roholl, P. J.; Joling, P.; Goudsmit, J.; Schuurman, H. J. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro, infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. J. Gen. Virol., 1993, 74(Pt 1), 129-135.
86. Orentas, R. J.; Hildreth, J. E. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum. Retroviruses, 1993, 9(11), 1157-1165.
87. Gluschankof, P.; Mondor, I.; Gelderblom, H. R.; Sattentau, Q. J. Cell membrane vesicles are a major contaminant of gradientenriched human immunodeficiency virus type-1 preparations. Virology, 1997, 230(1), 125-133.
88. Izquierdo-Useros, N.; Naranjo-Gomez, M.; Erkizia, I.; Puertas, M. C.; Borras, F. E.; Blanco, J.; Martinez-Picado, J. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog, 2010, 6(3), e1000740.
89. Sato, K.; Aoki, J.; Misawa, N.; Daikoku, E.; Sano, K.; Tanaka, Y.; Koyanagi, Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol., 2008, 82(2), 1021-1033.
90. Chertova, E.; Chertov, O.; Coren, L. V.; Roser, J. D.; Trubey, C. M.; Bess, J. W., Jr.; Sowder, R. C., 2nd; Barsov, E.; Hood, B. L.; Fisher, R. J.; Nagashima, K.; Conrads, T. P.; Veenstra, T. D.; Lifson, J. D.; Ott, D. E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol., 2006, 80(18), 9039-9052.
91. Pelchen-Matthews, A.; Kramer, B.; Marsh, M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol., 2003, 162, (3), 443-455.
92. Ruiz-Mateos, E.; Pelchen-Matthews, A.; Deneka, M.; Marsh, M. CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages. J. Virol., 2008, 82(10), 4751-4761.
93. Wiley, R. D.; Gummuluru, S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. USA, 2006, 103(3), 738-743.
94. Jolly, C.; Sattentau, Q. J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol., 2007, 81, (15), 7873-84.
95. Booth, A. M.; Fang, Y.; Fallon, J. K.; Yang, J. M.; Hildreth, J. E.; Gould, S. J. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol., 2006, 172, (6), 923-35.
96. Raposo, G.; Moore, M.; Innes, D.; Leijendekker, R.; Leigh-Brown, A.; Benaroch, P.; Geuze, H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic, 2002, 3, (10), 718-729.
97. Deneka, M.; Pelchen-Matthews, A.; Byland, R.; Ruiz-Mateos, E.; Marsh, M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol., 2007, 177, (2), 329-341.
98. Nguyen, D. G.; Booth, A.; Gould, S. J.; Hildreth, J. E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem., 2003, 278(52), 52347-52354.
99. Welsch, S.; Keppler, O. T.; Habermann, A.; Allespach, I.; Krijnse-Locker, J.; Krausslich, H. G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog., 2007, 3(3), e36.
100. Garcia, E.; Nikolic, D. S.; Piguet, V. HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3. Traffic, 2008, 9(2), 200-214.
101. Garcia, E.; Pion, M.; Pelchen-Matthews, A.; Collinson, L.; Arrighi, J. F.; Blot, G.; Leuba, F.; Escola, J. M.; Demaurex, N.; Marsh, M.; Piguet, V. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic, 2005, 6(6), 488-501.
102. Nydegger, S.; Khurana, S.; Krementsov, D. N.; Foti, M.; Thali, M. Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J. Cell Biol., 2006, 173(5), 795-807.
103. Harrist, A. V.; Ryzhova, E. V.; Harvey, T.; Gonzalez-Scarano, F. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells. PLoS ONE, 2009, 4(3), e5020.
104. Krementsov, D. N.; Rassam, P.; Margeat, E.; Roy, N. H.; Schneider-Schaulies, J.; Milhiet, P. E.; Thali, M. HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic, 2010, 11(11), 1401-1414.
105. Ono, A.; Freed, E. O. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol., 2004, 78(3), 1552-1563.
106. Lindwasser, O. W.; Resh, M. D. Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies. J. Virol., 2004, 78(11), 6013-6023.
107. Kawada, S.; Goto, T.; Haraguchi, H.; Ono, A.; Morikawa, Y. Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag. J. Virol., 2008, 82(9), 4384-4399.
108. Gan, X.; Gould, S. J. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol. Biol. Cell, 2011, 22(6),817-830
109. Weng, J.; Krementsov, D. N.; Khurana, S.; Roy, N. H.; Thali, M. Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells. J. Virol., 2009, 83(15), 7467-7474.
110. Rudnicka, D.; Feldmann, J.; Porrot, F.; Wietgrefe, S.; Guadagnini, S.; Prevost, M. C.; Estaquier, J.; Haase, A. T.; Sol-Foulon, N.; Schwartz, O. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol., 2009, 83(12), 6234-6246.
111. Krementsov, D. N.; Weng, J.; Lambele, M.; Roy, N. H.; Thali, M. Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology, 2009, 6, 64.
112. Thompson, W. W.; Shay, D. K.; Weintraub, E.; Brammer, L.; Cox, N.; Anderson, L. J.; Fukuda, K. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama, 2003, 289(2), 179-186.
113. Bouvier, N. M.; Palese, P. The biology of influenza viruses. Vaccine, 2008, 26(Suppl 4), D49-53.
114. Chu, C. M.; Dawson, I. M.; Elford, W. J. Filamentous forms associated with newly isolated influenza virus. Lancet, 1949, 1, (6554), 602.
115. Rust, M. J.; Lakadamyali, M.; Zhang, F.; Zhuang, X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat. Struct. Mol. Biol., 2004, 11(6), 567-573.
116. Sieczkarski, S. B.; Whittaker, G. R. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol., 2002, 76(20), 10455-10464.
117. Rossman, J. S.; Lamb, R. A. Influenza virus assembly and budding. Virology, 2011, 411(2), 229-236.
118. Schmitt, A. P.; Lamb, R. A. Influenza virus assembly and budding at the viral budozone. Adv. Virus Res., 2005, 64, 383-416.
119. Chen, B. J.; Takeda, M.; Lamb, R. A. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J. Virol., 2005, 79(21), 13673-13684.
120. Khurana, S.; Krementsov, D. N.; de Parseval, A.; Elder, J. H.; Foti, M.; Thali, M. Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. J. Virol., 2007, 81(22), 12630-12640.
121. Shaw, M. L.; Stone, K. L.; Colangelo, C. M.; Gulcicek, E. E.; Palese, P. Cellular proteins in influenza virus particles. PLoS Pathog., 2008, 4(6), e1000085.
122. Konig, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H. H.; Bhattacharyya, S.; Alamares, J. G.; Tscherne, D. M.; Ortigoza, M. B.; Liang, Y.; Gao, Q.; Andrews, S. E.; Bandyopadhyay, S.; De Jesus, P.; Tu, B. P.; Pache, L.; Shih, C.; Orth, A.; Bonamy, G.; Miraglia, L.; Ideker, T.; Garcia-Sastre, A.; Young, J. A.; Palese, P.; Shaw, M. L.; Chanda, S. K. Human host factors required for influenza virus replication. Nature, 2010, 463(7282), 813-817.
123. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K. P.; Artarini, A.; Heuer, D.; Becker, D.; Khalil, H.; Ogilvie, L. A.; Hess, S.; Maurer, A. P.; Muller, E.; Wolff, T.; Rudel, T.; Meyer, T. F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 2010, 463(7282), 818-822.
124. Sandrin, V.; Cosset, F. L. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem., 2006, 281(1), 528-542.
125. Thali, M. Tetraspanin functions during HIV-1 and influenza virus replication. Biochem. Soc. Trans., 2011, 39(2), 529-531.
126. Manns, A.; Hisada, M.; La Grenade, L. Human T-lymphotropic virus type I infection. Lancet, 1999, 353(9168), 1951-1958.
127. Yamamoto, N.; Hinuma, Y. Viral aetiology of adult T-cell leukaemia. J. Gen. Virol., 1985, 66(Pt 8), 1641-1660.
128. Fukudome, K.; Furuse, M.; Imai, T.; Nishimura, M.; Takagi, S.; Hinuma, Y.; Yoshie, O. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol., 1992, 66(3), 1394-1401.
129. Imai, T.; Fukudome, K.; Takagi, S.; Nagira, M.; Furuse, M.; Fukuhara, N.; Nishimura, M.; Hinuma, Y.; Yoshie, O. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol., 1992, 149(9), 2879-2886.
130. Pique, C.; Lagaudriere-Gesbert, C.; Delamarre, L.; Rosenberg, A. R.; Conjeaud, H.; Dokhelar, M. C. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission. Virology, 2000, 276(2), 455-465.
131. Mazurov, D.; Ilinskaya, A.; Heidecker, G.; Lloyd, P.; Derse, D. Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog., 2010, 6(2), e1000788.
132. Mazurov, D.; Heidecker, G.; Derse, D. HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane. Virology, 2006, 346(1), 194-204.
133. Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond), 2006, 110(5), 525-541.
134. Giroglou, T.; Florin, L.; Schafer, F.; Streeck, R. E.; Sapp, M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol., 2001, 75(3), 1565-1570.
135. Day, P. M.; Lowy, D. R.; Schiller, J. T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology, 2003, 307(1), 1-11.
136. Spoden, G.; Freitag, K.; Husmann, M.; Boller, K.; Sapp, M.; Lambert, C.; Florin, L. Clathrin-and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspaninenriched microdomains (TEMs). PLoS ONE, 2008, 3(10), e3313.
137. Corzo, C. A.; Mondaca, E.; Wayne, S.; Torremorell, M.; Dee, S.; Davies, P.; Morrison, R. B. Control and elimination of porcine reproductive and respiratory syndrome virus. Virus Res., 2010, 154, (1-2), 185-192.
138. Van Gorp, H.; Van Breedam, W.; Delputte, P. L.; Nauwynck, H. J. Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J. Gen. Virol., 2008, 89, (Pt 12), 2943-2953.
139. Shanmukhappa, K.; Kim, J. K.; Kapil, S. Role of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection. Virol J., 2007, 4, 62.
140. Yu, W.; Leibowitz, J. L. A conserved motif at the 3' end of mouse hepatitis virus genomic RNA required for host protein binding and viral RNA replication. Virology, 1995, 214(1), 128-138.
141. Hoffmann-Fezer, G.; Thum, J.; Ackley, C.; Herbold, M.; Mysliwietz, J.; Thefeld, S.; Hartmann, K.; Kraft, W. Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol., 1992, 66(3), 1484-1488.
142. Willett, B.; Hosie, M.; Shaw, A.; Neil, J. Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. J. Gen. Virol., 1997, 78(Pt 3), 611-618.;
143. Willett, B. J.; Hosie, M. J.; Jarrett, O.; Neil, J. C. Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology, 1994, 81, (2), 228-33
144. Willett, B. J.; Neil, J. C. cDNA cloning and eukaryotic expression of feline CD9. Mol. Immunol., 1995, 32(6), 417-423.
145. de Parseval, A.; Lerner, D. L.; Borrow, P.; Willett, B. J.; Elder, J. H. Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J. Virol., 1997, 71(8), 5742-5749.
146. Martella, V.; Elia, G.; Buonavoglia, C. Canine distemper virus. Vet Clin. N. Am. Small Anim. Pract., 2008, 38(4), 787-797, vii-viii.
147. Loffler, S.; Lottspeich, F.; Lanza, F.; Azorsa, D. O.; ter Meulen, V.; Schneider-Schaulies, J. CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol., 1997, 71(1), 42-49.
148. Schmid, E.; Zurbriggen, A.; Gassen, U.; Rima, B.; ter Meulen, V.; Schneider-Schaulies, J. Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion. J. Virol., 2000, 74(16), 7554-7561.
149. Singethan, K.; Topfstedt, E.; Schubert, S.; Duprex, W. P.; Rima, B. K.; Schneider-Schaulies, J. CD9-dependent regulation of Canine distemper virus-induced cell-cell fusion segregates with the extracellular domain of the haemagglutinin. J. Gen. Virol., 2006, 87(Pt 6), 1635-1642.
150. Singethan, K.; Muller, N.; Schubert, S.; Luttge, D.; Krementsov, D. N.; Khurana, S. R.; Krohne, G.; Schneider-Schaulies, S.; Thali, M.; Schneider-Schaulies, J. CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion. Traffic, 2008, 9(6), 924-935.
151. Douglas, M. W.; Diefenbach, R. J.; Homa, F. L.; Miranda-Saksena, M.; Rixon, F. J.; Vittone, V.; Byth, K.; Cunningham, A. L. Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J. Biol. Chem., 2004, 279(27), 28522-28530.
152. Wang, L.; Liu, L.; Che, Y.; Jiang, L.; Dong, C.; Zhang, Y.; Li, Q. Egress of HSV-1 capsid requires the interaction of VP26 and a cellular tetraspanin membrane protein. Virol. J., 2010, 7, 156.
153. Kurzeder, C.; Koppold, B.; Sauer, G.; Pabst, S.; Kreienberg, R.; Deissler, H. CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. Int. J. Mol. Med., 2007, 19(2), 325-333.
154. Fraile-Ramos, A.; Pelchen-Matthews, A.; Risco, C.; Rejas, M. T.; Emery, V. C.; Hassan-Walker, A. F.; Esteban, M.; Marsh, M. The ESCRT machinery is not required for human cytomegalovirus envelopment. Cell Microbiol., 2007, 9(12), 2955-2967.
155. Segura, M. M.; Garnier, A.; Di Falco, M. R.; Whissell, G.; Meneses-Acosta, A.; Arcand, N.; Kamen, A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J. Virol., 2008, 82(3), 1107-1117.
156. Vanderplasschen, A.; Mathew, E.; Hollinshead, M.; Sim, R. B.; Smith, G. L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA, 1998, 95(13), 7544-7549
157. Krauss, O.; Hollinshead, R.; Hollinshead, M.; Smith, G. L. An investigation of incorporation of cellular antigens into vaccinia virus particles. J. Gen. Virol., 2002, 83(Pt 10), 2347-2359.
158. Halasz, P.; Fleming, F. E.; Coulson, B. S. Evaluation of specificity and effects of monoclonal antibodies submitted to the Eighth Human Leucocyte Differentiation Antigen Workshop on rotaviruscell attachment and entry. Cell Immunol., 2005, 236(1-2), 179-187.
159. Svanborg, C.; Godaly, G., Bacterial virulence in urinary tract infection. Infect. Dis. Clin. N. Am., 1997, 11(3), 513-529.
160. Wu, X. R.; Sun, T. T.; Medina, J. J. In vitro, binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc. Natl. Acad. Sci. USA, 1996, 93(18), 9630-9635.
161. Zhou, G.; Mo, W. J.; Sebbel, P.; Min, G.; Neubert, T. A.; Glockshuber, R.; Wu, X. R.; Sun, T. T.; Kong, X. P. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro, FimH binding. J. Cell Sci., 2001, 114(Pt 22), 4095-4103.
162. Xie, J.; Foxman, B.; Zhang, L.; Marrs, C. F. Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder. J. Clin. Microbiol., 2006, 44(7), 2434-2441.
163. Mulvey, M. A.; Lopez-Boado, Y. S.; Wilson, C. L.; Roth, R.; Parks, W. C.; Heuser, J.; Hultgren, S. J. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science, 1998, 282, (5393), 1494-1497.
164. Mulvey, M. A.; Schilling, J. D.; Hultgren, S. J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun., 2001, 69(7), 4572-4579.
165. Bishop, B. L.; Duncan, M. J.; Song, J.; Li, G.; Zaas, D.; Abraham, S. N. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med., 2007, 13(5), 625-630.
166. Cossart, P.; Toledo-Arana, A. Listeria monocytogenes, a unique model in infection biology: an overview. Microbes. Infect., 2008, 10(9), 1041-1050.
167. Seveau, S.; Pizarro-Cerda, J.; Cossart, P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes. Infect., 2007, 9(10), 1167-1175.
168. Pizarro-Cerda, J.; Payrastre, B.; Wang, Y. J.; Veiga, E.; Yin, H. L.; Cossart, P. Type II phosphatidylinositol 4-kinases promote Listeria monocytogenes entry into target cells. Cell Microbiol., 2007, 9, (10), 2381-2390.
169. Yauch, R. L.; Hemler, M. E. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem. J., 2000, 351(Pt 3), 629-637.
170. Tham, T. N.; Gouin, E.; Rubinstein, E.; Boucheix, C.; Cossart, P.; Pizarro-Cerda, J. Tetraspanin CD81 is required for Listeria monocytogenes invasion. Infect. Immun., 2010, 78(1), 204-209.
171. Schachter, J. The intracellular life of Chlamydia. Curr. Top. Microbiol. Immunol., 1988, 138, 109-139.
172. Beatty, W. L. Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J. Cell Sci., 2006, 119(Pt 2), 350-359.
173. Beatty, W. L. Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect. Immun., 2008, 76(7), 2872-2881.
174. Tunbridge, A.; Read, R. C. Management of meningitis. Clin. Med., 2004, 4(6), 499-505.
175. Hill, D. J.; Griffiths, N. J.; Borodina, E.; Virji, M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin. Sci., (Lond), 2010, 118(9), 547-564.
176. Binker, M. G.; Cosen-Binker, L. I.; Terebiznik, M. R.; Mallo, G. V.; McCaw, S. E.; Eskelinen, E. L.; Willenborg, M.; Brumell, J. H.; Saftig, P.; Grinstein, S.; Gray-Owen, S. D. Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2. Cell Microbiol., 2007, 9(9), 2153-2166.
177. Hauck, C. R.; Meyer, T. F. 'Small' talk: Opa proteins as mediators of Neisseria-host-cell communication. Curr. Opin. Microbiol., 2003, 6(1), 43-49.
178. Join-Lambert, O.; Morand, P. C.; Carbonnelle, E.; Coureuil, M.; Bille, E.; Bourdoulous, S.; Nassif, X. Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis. Prog. Neurobiol., 2010, 91(2), 130-139.
179. Kallstrom, H.; Liszewski, M. K.; Atkinson, J. P.; Jonsson, A. B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol., 1997, 25(4), 639-647.
180. Tobiason, D. M.; Seifert, H. S. Inverse relationship between pilusmediated gonococcal adherence and surface expression of the pilus receptor, CD46. Microbiology, 2001, 147(Pt 8), 2333-2340.
181. Virji, M.; Watt, S. M.; Barker, S.; Makepeace, K.; Doyonnas, R. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol., 1996, 22, (5), 929-939.
182. Green, L. R.; Monk, P. N.; Partridge, L. J.; Morris, P.; Gorringe, A. R.; Read, R. C. Cooperative role for tetraspanins in adhesinmediated attachment of bacterial species to human epithelial cells. Infect. Immun., 2011, 79(6),2241-2249.
183. Martinez-Lorenzo, M. J.; Meresse, S.; de Chastellier, C.; Gorvel, J. P. Unusual intracellular trafficking of Salmonella typhimurium in human melanoma cells. Cell Microbiol., 2001, 3(6), 407-416.
184. Meyer-Wentrup, F.; Figdor, C. G.; Ansems, M.; Brossart, P.; Wright, M. D.; Adema, G. J.; van Spriel, A. B. Dectin-1 interaction with tetraspanin CD37 inhibits IL-6 production. J. Immunol., 2007, 178, (1), 154-162.
185. Mantegazza, A. R.; Barrio, M. M.; Moutel, S.; Bover, L.; Weck, M.; Brossart, P.; Teillaud, J. L.; Mordoh, J. CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood, 2004, 104, (4), 1183-1190.
186. Artavanis-Tsakonas, K.; Love, J. C.; Ploegh, H. L.; Vyas, J. M. Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification. Proc. Natl. Acad. Sci. USA, 2006, 103, (43), 15945-15950.
187. Tucker, S. C.; Casadevall, A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. USA, 2002, 99(5), 3165-3170.
188. Artavanis-Tsakonas, K.; Kasperkovitz, P. V.; Papa, E.; Cardenas, M. L.; Khan, N. S.; Van der Veen, A. G.; Ploegh, H. L.; Vyas, J. M. The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification. Infect. Immun., 2011, 79(3), 1098-1106.
189. Engering, A.; Pieters, J. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int. Immunol., 2001, 13(2), 127-134.
190. Kropshofer, H.; Spindeldreher, S.; Rohn, T. A.; Platania, N.; Grygar, C.; Daniel, N.; Wolpl, A.; Langen, H.; Horejsi, V.; Vogt, A. B. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol., 2002, 3(1), 61-68.
191. Alvarez, M.; Casadevall, A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol., 2006, 16(21), 2161-2165.
192. Ma, H.; Croudace, J. E.; Lammas, D. A.; May, R. C. Expulsion of live pathogenic yeast by macrophages. Curr. Biol., 2006, 16(21), 2156-2160.
193. Craft, J. C. Challenges facing drug development for malaria. Curr. Opin. Microbiol., 2008, 11(5), 428-433.
194. Prudencio, M.; Rodriguez, A.; Mota, M. M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol., 2006, 4(11), 849-856.
195. Silvie, O.; Rubinstein, E.; Franetich, J. F.; Prenant, M.; Belnoue, E.; Renia, L.; Hannoun, L.; Eling, W.; Levy, S.; Boucheix, C.; Mazier, D. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med., 2003, 9(1), 93-96.
196. Silvie, O.; Greco, C.; Franetich, J. F.; Dubart-Kupperschmitt, A.; Hannoun, L.; van Gemert, G. J.; Sauerwein, R. W.; Levy, S.; Boucheix, C.; Rubinstein, E.; Mazier, D. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell Microbiol., 2006, 8(7), 1134-1146.
197. Silvie, O.; Franetich, J. F.; Boucheix, C.; Rubinstein, E.; Mazier, D. Alternative invasion pathways for Plasmodium berghei sporozoites. Int. J. Parasitol., 2007, 37(2), 173-182.
198. Yalaoui, S.; Zougbede, S.; Charrin, S.; Silvie, O.; Arduise, C.; Farhati, K.; Boucheix, C.; Mazier, D.; Rubinstein, E.; Froissard, P. Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog., 2008, 4(2), e1000010.
199. Charrin, S.; Yalaoui, S.; Bartosch, B.; Cocquerel, L.; Franetich, J. F.; Boucheix, C.; Mazier, D.; Rubinstein, E.; Silvie, O. The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection. J. Biol. Chem., 2009, 284(46), 31572-31578.
200. Yalaoui, S.; Huby, T.; Franetich, J. F.; Gego, A.; Rametti, A.; Moreau, M.; Collet, X.; Siau, A.; van Gemert, G. J.; Sauerwein, R. W.; Luty, A. J.; Vaillant, J. C.; Hannoun, L.; Chapman, J.; Mazier, D.; Froissard, P. Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection. Cell Host Microb., 2008, 4(3), 283-292.
201. Sethi, S.; Wrona, C.; Eschberger, K.; Lobbins, P.; Cai, X.; Murphy, T. F. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2008, 177(5), 491-497.
202. Morey, P.; Cano, V.; Marti-Lliteras, P.; Lopez-Gomez, A.; Regueiro, V.; Saus, C.; Bengoechea, J. A.; Garmendia, J. Evidence for a non-replicative intracellular stage of nontypable Haemophilus influenzae in epithelial cells. Microbiology, 2011, 157(Pt 1), 234-250.
203. Astarie-Dequeker, C.; N'Diaye, E. N.; Le Cabec, V.; Rittig, M. G.; Prandi, J.; Maridonneau-Parini, I. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. Immun., 1999, 67(2), 469-477.
204. Welin, A.; Raffetseder, J.; Eklund, D.; Stendahl, O.; Lerm, M. Importance of phagosomal functionality for growth restriction of mycobacterium tuberculosis in primary human macrophages. J. Innate. Immun., 2011, 3(5),508-518
205. Maurin, M.; Raoult, D. Q fever. Clin. Microbiol. Rev., 1999, 12(4), 518-553.
206. Voth, D. E.; Heinzen, R. A. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol., 2007, 9(4), 829-840.
207. Howe, D.; Shannon, J. G.; Winfree, S.; Dorward, D. W.; Heinzen, R. A. Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages. Infect. Immun., 2010, 78(8), 3465-3474.
208. Laskay, T.; van Zandbergen, G.; Solbach, W. Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol., 2003, 11(5), 210-214.
209. Mollinedo, F.; Janssen, H.; de la Iglesia-Vicente, J.; Villa-Pulgarin, J. A.; Calafat, J. Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils. J. Biol. Chem., 2010, 285(45), 34528-34536.
210. Hassuna, N.; Monk, P. N.; Moseley, G. W.; Partridge, L. J. Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections. BioDrugs, 2009, 23(6), 341-359.
211. Dhanasekaran, M.; Baures, P. W.; VanCompernolle, S.; Todd, S.; Prakash, O. Structural characterization of peptide fragments from hCD81-LEL. J. Pept. Res., 2003, 61, (2), 80-89.
212. VanCompernolle, S. E.; Wiznycia, A. V.; Rush, J. R.; Dhanasekaran, M.; Baures, P. W.; Todd, S. C. Small molecule inhibition of hepatitis C virus E2 binding to CD81. Virology, 2003, 314(1), 371-380.
213. Meuleman, P.; Hesselgesser, J.; Paulson, M.; Vanwolleghem, T.; Desombere, I.; Reiser, H.; Leroux-Roels, G. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology, 2008, 48(6), 1761-1768.
214. Molina, S.; Castet, V.; Pichard-Garcia, L.; Wychowski, C.; Meurs, E.; Pascussi, J. M.; Sureau, C.; Fabre, J. M.; Sacunha, A.; Larrey, D.; Dubuisson, J.; Coste, J.; McKeating, J.; Maurel, P.; Fournier-Wirth, C. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J. Virol., 2008, 82(1), 569-574.
215. Gordon-Alonso, M.; Yanez-Mo, M.; Barreiro, O.; Alvarez, S.; Munoz-Fernandez, M. A.; Valenzuela-Fernandez, A.; Sanchez-Madrid, F. Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J. Immunol., 2006, 177(8), 5129-5137.
216. Grigorov, B.; Attuil-Audenis, V.; Perugi, F.; Nedelec, M.; Watson, S.; Pique, C.; Darlix, J. L.; Conjeaud, H.; Muriaux, D. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology, 2009, 6, 28.
217. van Spriel, A. B.; Figdor, C. G. The role of tetraspanins in the pathogenesis of infectious diseases. Microbes. Infect., 2010, 12(2), 106-112.